ABT vs MSFT: Which Stock is Better?
Side-by-side comparison of Abbott Laboratories and Microsoft Corp in 2026
ABT
Abbott Laboratories
$124.30
MSFT
Microsoft Corp
$470.67
Key Metrics Comparison
| Metric | ABT | MSFT | Winner |
|---|---|---|---|
| Market Cap | $216.93B | $3.50T | MSFT |
| P/E Ratio | 15.66 | 36.30 | ABT |
| EPS (TTM) | $7.96 | $13.70 | MSFT |
| Revenue Growth | 0.1% | 14.9% | MSFT |
| Gross Margin | 56.3% | 68.8% | MSFT |
Analyze ABT
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ABT or MSFT a better investment?
Comparing ABT and MSFT: Abbott Laboratories has a market cap of $216.93B while Microsoft Corp has $3.50T. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ABT and MSFT?
ABT (Abbott Laboratories) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ABT or MSFT?
Based on P/E ratios, ABT trades at a lower multiple (15.7x vs 36.3x).
Which is growing faster: ABT or MSFT?
MSFT has higher revenue growth at 14.9% vs 0.1% for ABT.
Which company is more profitable: ABT or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.8% compared to 56.3% for ABT.
Which is the larger company: ABT or MSFT?
Microsoft Corp (MSFT) is larger with a market cap of $3.50T compared to $216.93B for ABT.
Should I buy ABT or MSFT in 2026?
Both ABT and MSFT have investment merit. ABT trades at $124.30 while MSFT trades at $470.67. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ABT and MSFT stock?
Key differences: Market Cap ($216.93B vs $3.50T), P/E Ratio (15.7x vs 36.3x), Revenue Growth (0.1% vs 14.9%), Gross Margin (56.3% vs 68.8%).